<scp>P4HA2</scp> ‐mediated <scp>HIF</scp> ‐1α stabilization promotes erdafitinib‐resistance in <scp>FGFR3</scp> ‐alteration bladder cancer

MLA

Xuexiang Li, et al. “P4HA2 ‐mediated HIF ‐1α Stabilization Promotes Erdafitinib‐resistance in FGFR3 ‐alteration Bladder Cancer.” The FASEB Journal, vol. 37, Mar. 2023. EBSCOhost, https://doi.org/10.1096/fj.202201247r.

APA

Xuexiang Li, Yunxue Li, Bing Liu, Liang Chen, Fang Lyu, Pu Zhang, Qingliu He, Lulin Cheng, Chunyu Liu, Yarong Song, & Yifei Xing. (2023). P4HA2 ‐mediated HIF ‐1α stabilization promotes erdafitinib‐resistance in FGFR3 ‐alteration bladder cancer. The FASEB Journal, 37. https://doi.org/10.1096/fj.202201247r

Chicago

Xuexiang Li, Yunxue Li, Bing Liu, Liang Chen, Fang Lyu, Pu Zhang, Qingliu He, et al. 2023. “P4HA2 ‐mediated HIF ‐1α Stabilization Promotes Erdafitinib‐resistance in FGFR3 ‐alteration Bladder Cancer.” The FASEB Journal 37 (March). doi:10.1096/fj.202201247r.